Cathy Burton, MB BChir, MD, MRCP, FRCPath, St James’s University Hospital, Leeds, UK, introduces the updated British Society for Hematology (BSH) guidelines for managing newly diagnosed large B-cell lymphoma (DLBCL). The guidelines encompass novel first-line therapies like Pola-R-CHP, second-line CAR-T therapies, and third-line bispecific antibodies. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.